Maple Capital Management, Inc.
Source: SEC Form 13F · as of Mar 2026Maple Capital Management, Inc. holds 12 biotech & pharma companies tracked by BioSniper, totaling $116.8M in value as of Mar 2026 (SEC Form 13F).
Companies held
12
Total value held
$116.8M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 47,451 | $43.6M |
| JNJJOHNSON & JOHNSON | 171,979 | $42.0M |
| ABTABBOTT LABORATORIES | 168,652 | $17.3M |
| ZTSZoetis Inc. | 86,885 | $10.3M |
| MRKMerck & Co., Inc. | 8,393 | $1.0M |
| ABBVAbbVie Inc. | 3,801 | $827K |
| DGXQuest Diagnostics Incorporated | 2,313 | $453K |
| PMPhilip Morris International Inc | 2,297 | $380K |
| IDXXIDEXX LABORATORIES INC /DE | 469 | $264K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 791 | $214K |
| AMGNAMGEN INC | 606 | $213K |
| PFEPFIZER INC | 7,257 | $204K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.